1 Animal and epidemiological studies suggest that polyphenol constituents of red wine possess antioxidant activities that favour protection against cardiovascular disease ± the so-called.`French paradox' ± and possibly, central nervous system disorders such as Alzheimer's disease (AD) and ischaemia. 2 In the present study, the potential of three major red wine derived-polyphenols to protect against toxicity induced by the nitric oxide free radical donors sodium nitroprusside (SNP) and 3-morpholinosydnonimine (SIN-1) was examined in cultured rat hippocampal cells. 3 Both co-and post-treatments with either the stilbene resveratrol (5 ± 25 mM) or the¯avonoids quercetin (5 ± 25 mM) and (+)-catechin (1 ± 10 mM) were capable of attenuating hippocampal cell death and intracellular reactive oxygen species accumulation produced by SNP (100 mM and 1 mM, respectively). However, among the phenolic compounds tested, only the¯avonoids aorded signi®cant protection against 5 mM SIN-1-induced toxicity. 4 The eects of phenolic constituents were shared by Trolox (100 mM), a vitamin E analogue, but not by selective inhibitors of cyclo-oxygenases (COX) and lipoxygenases (LOX).
Introduction
The notion that red wine may have potential health bene®ts initially received a great deal of attention following reports that moderate wine consumption was linked to a lower incidence of cardiovascular disease ± the so-called`French Paradox' (Renaud & De Lorgevil, 1992) . A role for ethanol itself in the protective eects of red wine is however uncertain (for a review see Soleas et al., 1997; VanGolde et al., 1999) . In addition to ethanol, red wine contains a broad range of polyphenols that are present in the skin and seeds of grapes (Hertog et al., 1993; Goldberg et al., 1996; Celotti et al., 1996; Sato et al., 1997; Soleas et al., 1997) . Among them, the natural phytoalexin resveratrol (3,5,4'-trihydroxystilbene) and thē avonoids quercetin and (+)-catechin have been invoked in order to explain the bene®cial eects of moderate red wine consumption against coronary heart disease (Formica & Regelson, 1995; Pace-Asciak et al., 1995; Andriambeloson et al., 1997; Hayek et al., 1997; Rotondo et al., 1998; Tsai et al., 1999) . Possible mechanisms by which these phenolic compounds might exert their protective eects include their oxygen scavenging abilities and antioxidative properties (Belguendouz et al., 1997; Hayek et al., 1997; Plumb et al., 1998; Maccarronne et al., 1999) as well as their inhibitory eects on both the arachidonic acid cascade (Kimura et al., 1985; Formica & Regelson, 1995; Pace-Asciak et al., 1995; Maccarronne et al., 1999) and nitric oxide (NO) synthase activity (Kim et al., 1999; Tsai et al., 1999) .
In addition to red wine's purported cardioprotective eects, recent evidence suggests that wine consumption may also protect against certain neurological disorders. For example, epidemiological studies have shown that moderate red wine consumption is signi®cantly correlated with a reduction in both the incidence of age-related macular degeneration (Obisesan et al., 1998 ) and Alzheimer's disease (AD; Orgogozo et al., 1997) . Furthermore, in vivo animal studies have demonstrated the protective eects of quercetin (Shutenko et al., 1999) , resveratrol (Virgili & Contestabile, 2000) , and (+)-catechin (Inanami et al., 1998) in various models of neurotoxicity. Taken together, these latest ®ndings raise the possibility that red wine constituents may be bene®cial in the prevention of age-related neurodegenerative disorders.
Considering that oxidative stress is an age-related process implicated in various neurodegenerative disorders (Floyd, 1999) , we investigated the possible neuroprotective eects of the red wine constituents quercetin, resveratrol, and (+)-catechin on cell death induced by the well known nitric oxide (NO) free radical donors sodium nitroprusside (SNP) and 3-morpholinosydnonimine (SIN-1) (Dawson & Dawson, 1996) . The cellular pathways that lead from the generation of NO to cell death include its reaction with superoxide anions to form the potent oxidant peroxynitrite (Dawson & Dawson, 1996) , as well as NO's stimulatory eects on intracellular enzymes such as protein kinase C (PKC) (Maiese et al., 1993) and cyclooxygenase/lipoxygenase (Salvemini et al., 1993; Swierkosz et al., 1995 , Holzhutter et al., 1997 . The present experiments were performed in cultured cells of the hippocampus, an area severely aected in both AD and ischaemia (Mann et al., 1986; Schmidt-Kastner & Freund, 1991) and known to be particularly susceptible to oxidative stress (Furuta et al., 1995) .
Methods

Reagents
Materials used for cell cultures were obtained from Gibco BRL (Burlington, Ontario, Canada). 2-(1-thienyl)ethyl 3,4-dihydroxybenzylidenecyanoacetate was purchased from Tocris (Ballwin, MO, U.S.A.), whereas MK-886 was obtained from Calbiochem (San Diego, CA, U.S.A.). Unless stated otherwise, all other compounds including quercetin, resveratrol, and (+)-catechin were purchased from Sigma Chemical Co. (St-Louis, MO, U.S.A.).
Hippocampal cell cultures
Mixed (glial/neuronal) hippocampal cultured cells were prepared from E19 fetuses obtained from Sprague-Dawley rats (Charles River Canada, St-Constant, QueÂ bec, Canada) as described previously (Bastianetto et al., 2000) . Animal care was according to protocols and guidelines of the McGill University Animal Care Committee and the Canadian Council for Animal Care. Brie¯y, hippocampal cells were plated immediately after dissection at a density of about 5610 4 viable cells per well in 96-well plates coated with poly-D-lysine (10 mg ml 71 ). Cells were grown in D-MEM high glucose medium containing 2 mM sodium pyruvate, 25 mM KCl, 15 mM HEPES and 10% (v v 71 ) foetal bovine serum (FBS, ImmunoCorp, MontreÂ al, QueÂ bec, Canada) . Mixed cell cultures were obtained by removing the original medium at day 3 and replacing it by medium of the same composition. Cultures were maintained at 378C until day 7 in a humidi®ed atmosphere (5% CO 2 and 95% air).
Experimental treatments
On the day of the experiment, cells were co-treated for 20 h with either SNP (100 mM) or SIN-1 (5 mM) and the dierent test drugs that were dissolved in HEPES-buered MEM high glucose medium without FBS (pH 7.4). Following this incubation period, cell viability was determined using both the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and 3-amino-7-dimethyl-amino-2-methylphenazine hydrochloride (Neutral Red, NR) colorimetric assays, whereas ROS production was evaluated using the 2',7' dichloro¯uorescein (DCF)¯uorescence assay.
The rescuing ability of the dierent compounds was determined by pre-treating hippocampal cells with a HEPESbuered MEM high glucose medium containing SNP (1 mM) for a duration of 2 h. After the incubation period, the medium was removed and replaced with a similar one (without FBS and SNP) in the presence or absence of the dierent drugs tested. Cell viability (MTT and NR assays) and ROS production (DCF¯uorescence assay) were determined 24 h later.
Resveratrol (10 71 M) was freshly dissolved on the day of the experiment in 100% DMSO whereas all other drugs were freshly prepared as 2.5610 72 M stock solutions in 100% ethanol. These solvents had no eect by themselves on cell survival (data not shown).
Assessment of cell viability
Cell survival was evaluated 20 h later with the commonly used dye MTT, an indicator of mitochondrial respiratory chain activity (Liu et al., 1997) . Because free radicals are able to alter the activity of mitochondrial enzymes that are involved in MTT reduction (Sims, 1996) , we also used Neutral Red, a dye which is taken up by lysosomes of living cells, as an additional marker of hippocampal cell integrity (Bastianetto et al., 2000) . MTT reduction and NR uptake into living cells were quanti®ed at 570 nm and 540 nm, respectively, using a micro-plate reader (Bio-Tek Instruments 1 Inc., Ville StLaurent, QueÂ bec, Canada).
Assessment of intracellular free radicals
Intracellular free radical levels were estimated in parallel to cell survival using the DCF¯uorescent dye, as previously described (Mattson et al., 1995) . Application of 2,7-dichlorouorescein diacetate (25 mM; Molecular Probes Inc., Eugene, OR, U.S.A.) at the onset of experimental treatment results in a rapid conversion into 2',7'-dichloro¯uorescein which is then able to interact with intracellular free radicals to form thē uorescent dye DCF. DCF¯uorescence was quanti®ed at the end of the treatment period (excitation=485 nm, emission=530 nm) using a¯uorescence multiwell plate reader.
Measurement of protein kinase C activity
The activity of protein kinase C (PKC) was assessed on 7 dayold mixed hippocampal cells using a PKC assay kit (Signa TECT TM PKC Assay System, Promega, Madison, WI, U.S.A.) according to the protocol described previously (Bastianetto et al., 2000) . Brie¯y, cells were exposed for 5 min to either vehicle or SNP (100 mM, 5 min) in the presence or absence of 10 mM of each red wine constituent. Treated cells were immediately put on ice and rinsed with pre-cooled Hank's buer. Pre-cooled extraction buer was then added to each well and cells were scraped and homogenized in a pre-cooled dounce homogenizer. Cell lysates were incubated on ice for 20 min and centrifuged at 14,0006g for 10 min at 48C to remove cellular debris. Resulting supernatant was used to determine the activity of PKC. Speci®c activity of PKC was obtained by subtracting the radioactivity of the reaction in the presence of 100 mM of a PKC peptide inhibitor (Promega) from that of the reaction conducted without the PKC peptide inhibitor. All results were presented as per cent of the activity from cells exposed to vehicle (control group). (Swierkosz et al., 1995) . Hippocampal cells were exposed to SNP (100 mM) and either quercetin (10 mM), resveratrol (10 mM), or (+)-catechin (10 mM) in phenol red-free MEM. Concentrations of nitrite, the end-product of NO production, were quanti®ed 20 h later by adding 100 ml of Griess reagent to 40 ml samples of cell culture medium according to the manufacturer's protocol. The optical density at 540 nm was measured with the micro-plate reader. Nitrite concentrations were calculated by comparison with the optical density of a nitrate standard prepared in culture medium. The detection limit for nitrite measurement in culture medium was 0.5 mM.
Statistical analysis
Survival of vehicle-treated control groups not exposed to either SNP or the dierent drugs alone was de®ned as 100%. A oneway ANOVA followed by Newman Keuls' multiple comparisons or unpaired Student's t-tests were used to compare control and treated groups, with P values 50.05 being considered statistically signi®cant.
Results
Inhibitory eect of co-treatment with red wine constituents on SNP-induced toxicity and reactive oxygen species production Treatment of hippocampal cell cultures with the NO donor SNP (100 mM) resulted in cell damage of between 41 ± 50% (MTT values) and 39 ± 57% (NR values) ( Figure 1A ± C). Both the MTT and NR assays indicated that quercetin (5 ± 25 mM) strongly attenuated SNP-induced toxicity, producing a maximal eect on MTT and NR values at 25 mM ( Figure  1A ). This dierence between the two assays is likely explained by the fact that the MTT values of groups treated with quercetin (25 mM) alone were signi®cantly increased compared to vehicle-treated groups (100+1% (control) vs 130+4% (control+quercetin), P50.01), whereas the NR values remained unchanged (100+2% (control) 95+5% (control+ quercetin)). Resveratrol (5 ± 25 mM) was also able to increase cell survival, and this protective eect was signi®cant at 5 mM and maximal at the highest (25 mM) concentration tested ( Figure 1B ). As for (+)-catechin (1 ± 10 mM), it signi®cantly protected hippocampal cells at a concentration of 1 mM and had a maximal protective eect at the highest concentration tested here (10 mM) ( Figure 1C ). The MTT values, but not the NR values, of control groups treated with either resveratrol or (+)-catechin were signi®cantly higher compared to those of vehicle-treated control groups, and these eects were maximal at 5 mM of resveratrol (100+1% (control) vs 117+5% (control+resveratrol), P50.01) and 10 mM of (+)-catechin (100+2% (control) vs 115+4% (control+(+)-catechin), P50.01) ( Figure 1B,C) . However, none of these constituents induced a signi®cant increase in the MTT values compared to untreated cells when they were administered directly into the initial media (i.e. MEM in presence of FBS and without SNP), indicating that this increase is not related to neutrophic actions but might be due instead to changes and/or washes of the medium (data not shown).
Protective concentration-dependent eects were also observed when the cells were treated with either quercetin (5 ± 25 mM) or (+)-catechin (1 ± 10 mM) in the presence of SIN-1 (5 mM), a NO donor that also produces superoxide anions (Figure 2A,C) . These eects appeared to be maximal, and almost complete, at 10 mM (Figure 2A,C) . In contrast, a oneway ANOVA indicated that resveratrol (5 ± 25 mM) failed to dose-dependently protect against SIN-1-induced toxicity, although it tended to increase cell survival at the highest concentration tested (25 mM) (from 45 to 67% (MTT), from 41 to 59% (NR) ( Figure 2B ).
We have previously reported that SNP-induced toxicity is associated with a stimulation of reactive oxygen species (ROS) (Bastianetto et al., 2000) . As expected, the DCF assay indicated that SNP (100 mM) caused a signi®cant increase (*P50.01) in ROS accumulation (226 ± 288% above control values) 20 h following addition to the culture medium ( Figure  3A ± C) . This stimulatory eect of SNP on ROS production was signi®cantly attenuated by either quercetin (10 ± 25 mM), resveratrol (5 ± 25 mM), or (+)-catechin (5 ± 10 mM) in the same range of concentrations that protected hippocampal cells against SNP-induced toxicity ( Figure 3A ± C) . The attenuating abilities of phenolic compounds were signi®cant at 5 mM and maximal at the highest concentrations tested (10 mM or 25 mM) ( Figure 3A ± C) . ROS accumulation in cell cultures treated with either quercetin (5 and 25 mM), resveratrol (25 mM), or (+)-catechin (1 ± 10 mM) alone was also slightly, but signi®cantly, decreased compared to vehicle-treated control groups, suggesting that these red wine constituents can lower ROS accumulation in the absence of any toxic-inducing stimulus ( Figure 3A ± C) .
The inhibitory eects of these red wine constituents against toxic events initiated by SNP were shared by Trolox (100 mM), a vitamin E analogue that displays antioxidant activities (42+9 (SNP) vs 96+3 (SNP+Trolox), P50.01, (MTT); 38+2 (SNP) vs 96+2 (SNP+Trolox), P50.01 (NR); 239+26 (SNP) vs 112+9 (SNP+Trolox), P50.01, (DCF)).
Inhibitory eect of post-treatment with red wine constituents on SNP-induced toxicity and ROS production
Exposure of hippocampal cell cultures to SNP (1 mM) signi®cantly reduced cell viability (80% of MTT values and 84% of NR values, P50.01 and 0.05, respectively) when measured 2 h following application. When cell survival was assessed 24 h later, the MTT and NR values had decreased to 31 ± 56% and 33 ± 58%, respectively, and were associated with an increase in ROS production (148 ± 178% above control values).
We evaluated whether post-treatment with the dierent red wine constituents were capable of protecting hippocampal cells that were pre-exposed to SNP for a 2 h period. Interestingly, application of quercetin (5 ± 10 mM) resulted in an increase in MTT (from 43 to 65%) and NR values (from 43 to 74%) compared to control, as estimated 24 h later ( Figure 4A ). Resveratrol (5 ± 10 mM) also potently rescued hippocampal cells, with a maximal eect at the highest concentration tested (10 mM) ( Figure 4B ). (+)-Catechin (1 ± 5 mM) appeared to be the most ecacious and most potent constituent, with a signi®cant eect at 1 mM and an almost complete protective eect at 5 mM (from 44 to 98% of MTT values and from 48 to 88% of NR values) ( Figure 4C ). The rescuing eects of quercetin, resveratrol and (+)-catechin were accompanied by their abilities to reverse, in the same concentration range, intracellular ROS levels ( Figure 5) .
Similarly, a 2 h post-administration with Trolox (100 mM) resulted in an increase in cell survival that was accompanied by a signi®cant decrease in ROS production (32+4 (SNP) vs 69+4 (SNP+Trolox), P50.01 (MTT); 37+4 (SNP) vs 68+5 (SNP+Trolox), P50.01 (NR); 148+8 (SNP) vs 85+6 (SNP+Trolox), P50.01 (DCF)). Protective and rescuing effects of red wine constituents 714 S. Bastianetto et al
Lack of eect of selective lipoxygenase-and cyclo-oxygenase-inhibitors against SNP-induced toxicity
Prior results have shown that quercetin, resveratrol and (+)-catechin inhibit eicosanoid synthesis by inhibiting, at low micromolar concentration, either cyclo-oxygenase or lipox- Figure 2 Eect of co-treatment with quercetin (5 ± 25 mM) (A), resveratrol (5 ± 25 mM) (B) and (+)-catechin (1 ± 10 mM) (C) against toxicity induced by SIN-1 (5 mM), as estimated by the MTT and NR assays in rat hippocampal cell cultures. Values represent mean+ s.e.mean from 3 ± 4 independent experiments. *P50.05, **P50.01 compared to groups treated with SIN-1 alone. Figure 3 Eect of co-treatment with quercetin (5 ± 25 mM) (A), resveratrol (5 ± 25 mM) (B) and (+)-catechin (1 ± 10 mM) (C) on either 100 mM SNP-induced intracellular ROS in rat hippocampal cell cultures. Phenolic compounds were applied at the onset of SNP exposure. ROS were determined 20 h after by quanti®cation of DCF uorescence as described in Methods. Values represent mean+ s.e.mean from 3 ± 5 independent experiments. #P50.05, ##P50.01 compared to groups treated with vehicle, *P50.05, **P50.01 compared to groups treated SNP.
Protective and rescuing effects of red wine constituents 715 S. Bastianetto et al ygenase activities (Kimura et al., 1985; Pace-Asciak et al., 1995; Formica & Regelson, 1995; Maccarrone et al., 1999) . We therefore determined whether selective lipoxygenase-and cyclo-oxygenase-inhibitors oered protective eects against SNP-induced toxicity. Table 1 indicates that co-treatment with indomethacin (1 ± 5 mM), an inhibitor of cyclo-oxygenases COX-1 (IC 50 =740 nM) and COX-2 (IC 50 =970 nM) (Futaki et al., 1994) , did not protect hippocampal cells against SNPinduced toxicity, even at concentrations up to 10 mM (data not shown). Similarly, MK-886 (1 ± 5 mM), a potent and speci®c inhibitor of leukotriene biosynthesis (Menard et al., 1990) , failed to display any protective eects at concentrations known to prevent the activation of 5-lipoxygenase (Dixon, 1990) as did 2-(1-thienyl)ethyl 3,4-dihydroxybenzylidenecyanoacetate (1 ± 10 mM), a caeic acid derivative with potent lipoxygenase inhibitory activities (Cho et al., 1991) (Table 1) . Similarly, post-treatment with cyclo-oxygenase or lipoxygenase inhibitors did not rescue hippocampal cells pre-exposed to SNP (1 mM) ( Table 2 ). These inhibitors also failed to attenuate ROS accumulation (Tables 1 and 2 ).
Eects of red wine constituents on SNP-stimulated PKC activity and nitrite concentration As described previously (Bastianetto et al., 2000) , application of SNP (5 min, 100 mM) induced PKC activation in cultured hippocampal cells. Treatments with quercetin (10 mM) almost completely inhibited SNP-stimulated PKC activity (Figure 6 ). In contrast, resveratrol (10 mM) and (+)-catechin (10 mM) failed to modulate SNP-stimulated PKC activity ( Figure 6 ).
As previously reported (Koshimura et al., 1998) , an exposure to SNP (100 mM) increased nitrite levels in the culture medium (from 1 ± 21 mM of nitrite, P50.01). All red wine derived-phenolic compounds failed to attenuate the NO production at the same concentration (10 mM) that protected hippocampal cells against 100 mM SNP-induced toxicity, as estimated by the MTT assay ( Figure 7A,B) .
Discussion
The present study indicates that the¯avonoids quercetin and (+)-catechin, as well as the stilbene resveratrol, are able to protect, and more interestingly, to rescue hippocampal cells against toxicity induced by NO. These data, and those obtained in other cell types such as ®broblasts (Subirade et Figure 4 Eect of 2 h post-treatment with quercetin (5 ± 10 mM) (A), resveratrol (5 ± 10 mM) (B) and (+)-catechin (1 ± 5 mM) (C) against 1 mM SNP-induced toxicity, as estimated by the MTT and NR assays in rat hippocampal cell cultures. Values represent mean+s.e.mean from 3 ± 5 independent experiments. *P50.05, **P50.01 compared to groups treated with SNP alone. Figure 5 Eect of 2 h post-treatment with quercetin (5 ± 10 mM), resveratrol (5 ± 10 mM) and (+)-catechin (1 ± 5 mM) on against 1 mM SNP-induced intracellular ROS in rat hippocampal cell cultures. Phenolic compounds were applied 2 h after the onset of SNP exposure. ROS were determined 24 h after by quanti®cation of DCF uorescence as described in Methods. Values represent mean+ s.e.mean from 3 ± 5 independent experiments. *P50.01 compared to groups treated with either SNP.
al., 1995) and HT22 cells (Moosmann & Behl, 1999) , demonstrate that red wine-derived phenolic constituents can inhibit the deleterious events of oxidative stress produced by NO generation, a process that may be relevant to neurodegenerative events occurring during chronic in¯ammation, cerebral ischaemia (for a review see Hobbs et al., 1999) , or excitotoxicity (Dawson et al., 1991) .
Several studies have shown that NO-induced toxicity is engendered by its reaction with the superoxide anion radical
) to yield the highly cytotoxic ROS peroxynitrite. Peroxynitrite then decomposes to form nitrogen dioxide and Table 1 Lack of eect of co-treatment with selective cyclo-oxygenase-and lipoxygenase-inhibitors against SNP-induced toxicity in rat hippocampal cell cutures
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Values represent mean+s.e.mean from 3 ± 5 independent experiments. Table 2 Lack of eect of post-treatment with selective cyclo-oxygenase-and lipoxygenase-inhibitors against SNP-induced toxicity in rat hippocampal cell cultures
Values represent mean+s.e.mean of 4 ± 8 wells from 3 ± 5 independent experiments. Figure 6 Eect of quercetin (Que, 10 mM), resveratrol (Res, 10 mM) and (+)-catechin (Cat, 10 mM) on (100 mM, 5 min) SNP-induced PKC activity in rat hippocampal mixed cell cultures. PKC activity was measured as described in Methods. Values represent mean+ s.e.mean from ®ve independent experiments. *P50.01 compared to SNP-treated groups. the radical hydroxyl, leading to lipid peroxidation, protein oxidation, and DNA damage (Dawson & Dawson, 1996) . Both the purported antioxidant activities, as well as the ROS scavenging properties, of quercetin, resveratrol and (+)-catechin are likely to explain, at least in part, their protective and rescuing abilities. Indeed, all of these compounds shared with Trolox, a well known antioxidant and oxygen free radical scavenger, the ability to attenuate increases in SNP-stimulated ROS accumulation in the same concentration range for which they have been reported to inhibit free radicals-or metal ioninduced lipid peroxidation (Plumb et al., 1998; Belguendouz et al., 1997; Maccarrone et al., 1999) , or to scavenge free radicals such as superoxide anions (Robak & Gryglewski, 1988; Huk et al., 1998; Kostyuk & Potapovich, 1998) and peroxynitrite (Pannala et al., 1997; Nanjo et al., 1999) .
In addition to their antioxidant properties, red wine constituents have been reported to attenuate, in the same concentration range, levels of cyclo-oxygenase (prostaglandins) and lipoxygenase (leukotrienes, eicosatetraenoic acids) metabolites (Kimura et al., 1985; Formica & Regelson, 1995; Subbaramaiah et al., 1998; Maccarrone et al., 1999) known to be increased during ischaemia-reperfusion events (Rao et al., 1999) or after NO exposure (Tetsuka et al., 1994; Swierkosz et al., 1995) . However, neither indomethacin, nor MK-886 or 2-(1-thienyl)ethyl 3,4-dihydroxybenzylidenecyanoacetate were able to block events elicited by SNP, indicating that the protective/rescuing properties of red wine constituents are not likely triggered by their purported inhibitory action of the arachidonic acid cascade (Kimura et al., 1985; Formica & Regelson, 1995; Pace-Asciak et al., 1995; Subbaramaiah et al., 1998; Maccarrone et al., 1999) .
It has been suggested that the blockade of PKC activity is involved in the protection of NO-mediated toxicity (Maiese et al., 1993; Bastianetto et al., 2000) and that inhibition of nitrite oxide synthase (NOS) may be a potential therapeutic target in the treatment of pathophysiological states related to NO overproduction (Hobbs et al., 1999) . In the present study, only quercetin was able to block SNP-stimulated PKC activation, pointing to a possible involvement of this enzyme in the protective eects mediated by quercetin. These ®ndings are in agreement with previous studies showing that quercetin (10 mM), but not (+)-catechin (10 mM), inhibits TPA-induced PKC activation in ®broblast cells (Lee & Lin, 1997) . We also found that resveratrol (10 mM) failed to modulate SNP-stimulated PKC activity in our model. Although it has been reported that resveratrol (2.5 ± 30 mM) can inhibit TPA-induced PKC activity (Subbaramaiah et al., 1998) , our data are in accordance with other studies showing that resveratrol is a poor inhibitor of PKC when this enzyme is activated by either Ca 2+ / phosphatidylserine (IC 50 =90 mM) (Stewart et al., 1999) or phosphatidylcholine/phosphatidylserine (IC 50 =30 mM) (Garcia-Garcia et al., 1999). Moreover, none of the phenolic compounds tested were able to modulate the activity of NOS elicited by SNP (as measured by nitrite accumulation), indicating that the protective eects of red wine constituents are not likely associated to the inhibition of NOS. These ®ndings are in agreement with the previous report that quercetin has only a weak inhibitory eect (IC 50 =107 mM) on NO production, whereas (+)-catechin has none at all (Kim et al., 1999) . However, Tsai et al. (1999) found that resveratrol (10 mM) inhibited NO generation and suppressed inducible-NOS (iNOS) in lipopolysaccharide (LPS)-activated macrophages. This discrepancy may be due to dierences in experimental conditions, including cell types and toxic agents (LPS vs SNP).
Concentrations of quercetin (4 ± 16 mg ml 71 i.e. 12 ± 48 mM), resveratrol (0.1 ± 4.9 mg ml 71 i.e. 0.4 ± 21 mM), and (+)-catechin (1.5 mg ml 71 i.e. 5 mM) in red wine, depend upon vintage and type of grapes (Hertog et al., 1993; Goldberg et al., 1996; Celotti et al., 1996; Sato et al., 1997; Soleas et al., 1997) , and can reach those required to produce their purported in vitro protective eects as seen in the present study. Furthermore, Shutenko et al. (1999) demonstrated that a peripheral administration of quercetin increases the level of NO during rat brain ischaemia-reperfusion, suggesting that in vivo quercetin treatment can prevent the deleterious accumulation of superoxide occurring during ischaemia-reperfusion injury. However, its relatively poor absorptive properties in humans renders its potential therapeutic usefulness less likely (Formica & Regelson, 1995) .
Interestingly, it has recently been shown that a chronic administration of resveratrol partially protects rat hippocampal neurons against kainic acid-induced damage in vivo (Virgili & Contestabile, 2000) . Although the intake of red wine (per os) resulted in the detection of resveratrol concentrations in the plasma and other tissues of the rat that were in a pharmacologically active range (Bertelli et al., 1996; , the physiological signi®cance of resveratrol to daily human red wine consumers remains to be established (Soleas et al., 1997) . Nonetheless, the oral administration of the (7) racemer of catechin, which seems to appear the most ecient protective red wine constituent in our model, has been reported to protect hippocampal CA1 pyramidal cells against neurotoxicity induced by transient focal brain ischaemia in gerbils (Inanami et al., 1998) . This protective eect of the¯avanone catechin was also accompanied by an increase in superoxide scavenging activity in the brain of catechin-treated gerbils, suggesting that it is able to cross the blood-brain barrier (Inanami et al., 1998) . It is therefore conceivable that moderate, daily red wine consumption can provide sucient amounts of active phenolic compounds ± in particular resveratrol and catechin ± to oer neuroprotection. This assumption is supported by two recent and exhaustive epidemiological studies revealing the existence of a negative correlation between moderate red wine drinking and the occurrence of AD (Orgogozo et al., 1997) and agerelated macular degeneration (Obisesan et al., 1998) .
In summary, we have shown that red wine phenolic constituents are capable of both protecting and rescuing rat hippocampal cultured cells against NO-induced toxicity. These eects are likely mediated by antioxidant activities and do not appear to involve purported inhibitory eects on intracellular enzymes such as COX/LOX, NOS and, with the exception of quercetin, PKC. These data also support the hypothesis of bene®cial eects of daily red wine consumption against the occurrence of neuropathological diseases of either a chronic or acute nature, as well as on the natural process of aging in which over-production of free radicals is likely to play a deleterious role.
